Antidiabetic in pharma franchise in Nagaland

Antidiabetic in PCD pharma franchise in Bhubaneswar

Antidiabetic in top pharma company in Gangtok

Antidiabetic in pcd pharma supplier in Lucknow

Antidiabetic in phama franchise company in india
Antidiabetic in phama distributor in Thane

Home/Products /glimepiride-2mg-metformin-hydrochloride-tablet

Gimtype MP2 Tablet

Composition : Glimepiride 2mg + Metformin Hydrochloride I.P. 500mg + Pioglitazone 15mg Bi-Layered Tablets

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*15

Price : ₹139/-

Gimtype MP2 Tablet is a bi-layered formulation designed to provide comprehensive glycemic control in patients with type 2 diabetes mellitus (T2DM). It combines three well-established antidiabetic agents: Glimepiride (2mg), Metformin Hydrochloride (500mg), and Pioglitazone (15mg), each playing a crucial role in lowering blood glucose levels and improving insulin sensitivity.

Managing diabetes requires a multi-targeted approach, and Glimtype MP2 effectively addresses insulin resistance, glucose production, and insulin secretion deficiencies, helping to prevent long-term complications associated with diabetes.

Mechanism of Action:

Glimepiride (2mg): A sulfonylurea that enhances pancreatic beta-cell activity, leading to increased insulin secretion and effective blood glucose reduction.
Metformin Hydrochloride (500mg): A biguanide that reduces hepatic glucose production, improves insulin sensitivity, and enhances glucose uptake by muscle cells.
Pioglitazone (15mg): A thiazolidinedione that reduces insulin resistance, allowing the body to utilize insulin more efficiently and maintain balanced glucose levels.

Read More

About the Product

Gimtype MP2 Tablet is a bi-layered formulation designed to provide comprehensive glycemic control in patients with type 2 diabetes mellitus (T2DM). It combines three well-established antidiabetic agents: Glimepiride (2mg), Metformin Hydrochloride (500mg), and Pioglitazone (15mg), each playing a crucial role in lowering blood glucose levels and improving insulin sensitivity.

Managing diabetes requires a multi-targeted approach, and Glimtype MP2 effectively addresses insulin resistance, glucose production, and insulin secretion deficiencies, helping to prevent long-term complications associated with diabetes.

Mechanism of Action:

Glimepiride (2mg): A sulfonylurea that enhances pancreatic beta-cell activity, leading to increased insulin secretion and effective blood glucose reduction.
Metformin Hydrochloride (500mg): A biguanide that reduces hepatic glucose production, improves insulin sensitivity, and enhances glucose uptake by muscle cells.
Pioglitazone (15mg): A thiazolidinedione that reduces insulin resistance, allowing the body to utilize insulin more efficiently and maintain balanced glucose levels.

Possible side effects include hypoglycemia, nausea, dizziness, weight gain, fluid retention, mild gastrointestinal discomfort, and liver enzyme elevation. Seek medical attention if symptoms persist.

Used in the treatment of type 2 diabetes mellitus (T2DM) in adults who require combination therapy to achieve optimal glycemic control.

This medication should be taken under medical supervision. Regular blood sugar monitoring is essential to avoid hypoglycemia or hyperglycemia. Follow a healthy diet and exercise plan for the best therapeutic results.

Store in a cool, dry place, away from direct heat and moisture. Keep out of reach of children

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation